Status:

COMPLETED

Influence of Intermittent Hypoxia on Glycemic Control

Lead Sponsor:

University of Texas at Austin

Conditions:

Hypoxemia

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The aim of this research project is to determine the effect of intermittent hypoxia on glucose uptake in response to an oral glucose tolerance test in healthy individuals, individuals with prediabetes...

Detailed Description

For the past 100 years, cardiovascular disease has been the leading cause of death in the United States. An aging population, increasing levels of obesity and the predominance of a sedentary lifestyle...

Eligibility Criteria

Inclusion

  • Men and women aged 18 to 80 years old

Exclusion

  • Have uncontrolled stage 2 hypertension (˃140/90 mmHg)
  • Are smokers
  • Are pregnant
  • Have a history of cardiovascular disease or indication of cardiovascular disease such as myocardial infarction, left ventricular hypertrophy, ischemic heart disease (or prior ischemia), stroke, and/or other vascular disease
  • Have a history of lung disease
  • Are taking insulin or more than one antihypertensive medication
  • Have poorly controlled diabetes: HbA1c levels ˃ 9%
  • Have been previously diagnosed with diabetic complications (nephropathy, neuropathy, retinopathy) by their family doctor

Key Trial Info

Start Date :

February 5 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 26 2024

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT06490900

Start Date

February 5 2021

End Date

November 26 2024

Last Update

March 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Unviersity of Texas at Austin

Austin, Texas, United States, 78712